It has been reported that this polymorphism also determines glucose-stimulated insulin secretion and plasma glucose concentrations and thus increases the type 2 diabetes mellitus (T2DM) risk in European populations19. The gene discussed is INS; the disease is type 2 diabetes mellitus.